Assistant Professor, Medicine, Medical College of Wisconsin
Hematology
Dr. Wael Saber, MD
|
|
Give Review
Dr. Wael Saber works in the field of Hematology. Wael Saber, MD is also published. He has 34 publications published. The lastest publication: "Allogeneic hematopoietic cell transplantation for patients with mixed phenotype acute leukemia.' Wael Saber is registered with Medicare and accepts Medicare payments.
Publications
- Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission.
- Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.
- Early cytomegalovirus reactivation remains associated with increased transplant related mortality in the current era: a CIBMTR analysis.
- Allogeneic hematopoietic cell transplantation for patients with mixed phenotype Acute leukemia.
- Hematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age Groups.
- Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.
- New cancers after autotransplantations for multiple Myeloma.
- Guidelines for Defining and Implementing Standard Episode of Care for Hematopoietic Stem Cell Transplantation within the Context of Clinical Trials.
- Increasing incidence of chronic graft-versus-host Disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.
- Impact of Conditioning Regimen on Outcomes for Patients with Lymphoma Undergoing High-Dose Therapy with Autologous Hematopoietic Cell Transplantation.
- Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosis.
- Plerixafor and abbreviated-course granulocyte colony-stimulating factor for mobilizing hematopoietic progenitor cells in light chain amyloidosis.
- Comparison of Outcomes of Allogeneic Transplantation for CML with Cyclophosphamide in Combination with IntraVenous Busulfan, Oral Busulfan or TBI.
- Alternative donors extend transplantation for patients with Lymphoma who lack an HLA matched donor.
- Long-term Survival and Late Effects among 1-year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Synd...
- Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis.
- Non-permissive -DPB1 mismatch among otherwise HLA-matched donor-recipient pairs results in increased overall mortality after myeloablative unrelated allogeneic hematop...
- Early Failure of Frontline Rituximab-containing Chemoimmunotherapy in Diffuse Large B-Cell Lymphoma does not Predict Futility of Autologous Hematopoietic Cell Transpla...
- Second solid cancers after allogeneic hematopoietic cell transplantation using reduced intensity conditioning.
- Multicenter Biologic Assignment Trial Comparing Reduced-Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patien...
- Outcomes of Human Leukocyte Antigen-Matched Sibling Donor Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia: Myeloablative Versus Reduced-Intensity Co...
- Myelodysplastic syndromes in the United States: an update for clinicians.
- Validation and refinement of the Disease risk index for allogeneic stem cell transplantation: a study from the CIBMTR.
- Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhi...
- Outcomes of hematopoietic cell transplantation for diffuse large B cell Lymphoma transformed from follicular Lymphoma.
- Allotransplantation for patients age 40 years and greater with non-Hodgkin Lymphoma (NHL): encouraging progression-free survival.
- Effect of post remission therapy prior to reduced intensity conditioning allogeneic transplantation for Acute myeloid leukemia in first complete remission.
- Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow tran...
- Treatment of Older Patients with High-Risk Myelodysplastic Syndromes (MDS): The Emerging Role of Allogeneic Hematopoietic Stem Cell Transplantation (Allo HSCT).
- Does Total Body Irradiation Conditioning Improve Outcomes of Myeloablative Human Leukocyte Antigen-Identical Sibling Transplantations for Chronic Lymphocytic Leukemia?
- Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
- Impact of donor source on hematopoietic cell transplantation outcomes for patients with Myelodysplastic syndromes (MDS).
- Divergent Effects of Novel Immunomodulatory Agents and Cyclophosphamide on the Risk of Engraftment Syndrome after Autologous Peripheral Blood Stem Cell Transplantation...
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Coagulation Disorders (incl. Hemophilia)
- Deep Vein Thrombosis (DVT)
- View All
Doctors Specialties
- Hematology
Accepted Insurances
Education
-
University of Wisconsin -
Cleveland Clinic Foundation -
Ain Shams University Faculty of Medicine
Hospital
-
Froedtert Memorial Lutheran Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1730145863 |
| Last Name Of The Provider | SABER |
| First Name Of The Provider | WAEL |
| View All |
Similar Doctors
|
Dr. Gilbert C. White II, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Timothy S. Fenske, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Charles H. Tiber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael W. Schuetz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sara R. Torgerson, DO |
|
|
Dr. Amanda L. Wilson, MD
This Doctor is OpenDoctor Recommended.
|